Egualen
Alternative Names: Azuletil; Azuloxa; Egualene; KT1 32Latest Information Update: 02 Apr 2001
At a glance
- Originator Kotobuki Seiyaku
- Developer Kotobuki Pharmaceutical
- Class Antisecretories; Antiulcers; Azulenes; Sesquiterpenes; Small molecules
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Gastric ulcer